Acquired von Willebrand syndrome associated with left ventricular assist device

A Nascimbene, S Neelamegham… - Blood, The Journal …, 2016 - ashpublications.org
Left ventricular assist devices (LVAD) provide cardiac support for patients with end-stage
heart disease as either bridge or destination therapy, and have significantly improved the …

Flow-induced elongation of von Willebrand factor precedes tension-dependent activation

H Fu, Y Jiang, D Yang, F Scheiflinger, WP Wong… - Nature …, 2017 - nature.com
Von Willebrand factor, an ultralarge concatemeric blood protein, must bind to platelet GPIbα
during bleeding to mediate hemostasis, but not in the normal circulation to avoid thrombosis …

Type 2A and 2M von Willebrand disease: differences in phenotypic parameters according to the affected domain by disease-causing variants and assessment of …

AI Woods, J Paiva, DM Primrose… - … in Thrombosis and …, 2021 - thieme-connect.com
Type 2A and 2M von Willebrand disease (VWD) broadly show similar phenotypic
parameters, but involve different pathophysiological mechanisms. This report presents the …

Free hemoglobin increases von Willebrand factor–mediated platelet adhesion in vitro: implications for circulatory devices

Q Da, M Teruya, P Guchhait, J Teruya… - Blood, The Journal …, 2015 - ashpublications.org
Intravascular hemolysis occurs in patients on extracorporeal membrane oxygenation. High
levels of free acellular adult hemoglobin (free HbA) are associated with clotting in this …

The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα

L Ju, J Dong, MA Cruz, C Zhu - Journal of Biological Chemistry, 2013 - ASBMB
Binding of platelet glycoprotein Ibα (GPIbα) to von Willebrand factor (VWF) initiates platelet
adhesion to disrupted vascular surface under arterial blood flow. Flow exerts forces on the …

Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics

L Ju, Y Chen, F Zhou, H Lu, MA Cruz, C Zhu - Thrombosis research, 2015 - Elsevier
Circulating von Willebrand factor (VWF) adopts a closed conformation that shields the
platelet glycoprotein Ibα (GPIbα) binding site in the VWF-A1 domain. Immobilized at sites of …

[图书][B] Platelets in thrombotic and non-thrombotic disorders: pathophysiology, pharmacology and therapeutics: an update

P Gresele, NS Kleiman, JA Lopez, CP Page - 2017 - books.google.com
This book reviews current science and applications in fields including thrombosis and
hemostasis, signal transduction, and non-thrombotic conditions such as inflammation …

A novel interaction between extracellular vimentin and fibrinogen in fibrin formation

M Martinez-Vargas, A Cebula, LS Brubaker… - Thrombosis research, 2023 - Elsevier
Introduction Thrombosis is frequently manifested in critically ill patients with systemic
inflammation, including sepsis and COVID-19. The coagulopathy in systemic inflammation is …

von Willebrand factor, free hemoglobin and thrombosis in ECMO

C Valladolid, A Yee, MA Cruz - Frontiers in Medicine, 2018 - frontiersin.org
Though extracorporeal membrane oxygenation (ECMO) provides life-saving support, this
intervention exposes patients to certain risks. Circulating free hemoglobin (fHb) resulting …

Platelet adhesion involves a novel interaction between vimentin and von Willebrand factor under high shear stress

Q Da, M Behymer, JI Correa… - Blood, The Journal of …, 2014 - ashpublications.org
The interaction between platelet receptor glycoprotein Ibα and the A1 domain of von
Willebrand factor (VWF) mediates tethering/translocation of platelets to sites of vascular …